MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
National Research Corporation ROE Ratio 2011-2025 | NRC
Annual ROE Ratio National Research Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.26 | 44.15 | 43.9 | 57.93 | 98.52 | 157.45 | 25.48 | 24.78 | 23.73 | 20.69 | 21.58 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 157.45 | 20.69 | 52.86 |
Quarterly ROE Ratio National Research Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64.23 | 51.86 | 67.72 | 49.0 | 62.61 | 59.79 | 53.79 | 32.29 | 44.54 | 43.17 | 45.94 | 34.85 | 46.47 | 45.84 | 45.43 | 35.93 | 50.82 | 54.1 | 54.38 | 45.17 | 69.85 | 79.64 | 90.12 | 72.08 | 108.72 | 120.67 | 139.85 | 116.57 | 121.19 | 89.16 | 53.9 | 18.24 | 23.95 | 25.05 | 24.17 | 17.86 | 23.44 | 23.31 | 23.28 | 15.74 | 20.93 | 20.54 | 19.68 | 16.02 | 21.33 | 21.46 | 21.63 | 16.33 | 22.63 | 23.62 | 25.78 | 20.03 | 24.79 | 23.25 | 20.51 | 15.18 | 4.76 | 4.19 | 6.22 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 139.85 | 4.19 | 43.96 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 19.33 | 0.21 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 20.97 | -1.38 % | $ 226 M |  China |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M |  USA |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 0.23 | -4.4 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 39.53 | -1.4 % | $ 1.1 B | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.52 | - | $ 1.93 M | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 10.17 | 1.29 % | $ 289 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
26.18 | $ 67.51 | 0.13 % | $ 26.1 B | USA |
 |
Danaher Corporation
DHR
|
7.87 | $ 230.0 | -0.45 % | $ 168 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 101.56 | 0.02 % | $ 18.8 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 26.78 | -0.85 % | $ 810 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-72.81 | $ 19.47 | -1.32 % | $ 1.05 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 101.9 | -0.7 % | $ 4.02 B | USA |
 |
Anixa Biosciences
ANIX
|
-62.78 | $ 3.21 | -6.25 % | $ 102 K | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
22.63 | $ 226.52 | 0.26 % | $ 41.1 B | USA |
 |
Guardant Health
GH
|
312.48 | $ 103.35 | 0.94 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
-18.16 | $ 6.44 | -1.68 % | $ 583 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 135.12 | -0.15 % | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
0.64 | $ 203.88 | - | $ 10.5 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-449.46 | $ 4.94 | -3.14 % | $ 2.65 M | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 7.12 | -0.35 % | $ 1.54 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 176.16 | 0.15 % | $ 19.6 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 6.76 | -0.88 % | $ 877 M | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 254.32 | 0.02 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 182.75 | -0.51 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
55.65 | $ 688.22 | 0.01 % | $ 56.8 B | USA |
 |
Pacific Biosciences of California
PACB
|
-43.74 | $ 1.77 | -5.85 % | $ 449 M | USA |
 |
Lantheus Holdings
LNTH
|
28.72 | $ 66.73 | 0.07 % | $ 4.62 B | USA |
 |
Mettler-Toledo International
MTD
|
-680.23 | $ 1 419.64 | 0.11 % | $ 30.1 B |  Schweiz |
 |
Agilent Technologies
A
|
22.45 | $ 138.31 | 0.03 % | $ 42 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.7 | 1.9 % | $ 6.2 M | USA |
 |
Bioventus
BVS
|
-90.0 | $ 7.4 | 0.27 % | $ 464 M | USA |
 |
NeoGenomics
NEO
|
-8.72 | $ 12.33 | 0.2 % | $ 1.56 B | USA |